For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Metered-dose inhalers No.1 one villain: General practice small emissions source but key influencer
Metered-dose inhalers No.1 one villain: General practice small emissions source but key influencer

GPs play a vital part in reducing emissions by adopting strategies including reducing medication waste and promoting active transport, writes Dermot Coffey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1 Sawyer M, Thrower H. Carbon Footprint of GP Practices Across Humber and North Yorkshire ICS. SEE Sustainability 2022; January online. [http://tinyurl.com/3s8s733s]
2 Tennison I, Roschnik S, Ashby B, et al. Health care’s response to climate change: a carbon footprint assessment of the NHS in England. The Lancet Planetary Health 2021;5(2), e84–92
3 Nicolet J, Mueller Y, Paruta P, et al. What is the carbon footprint of primary care practices? A retrospective life-cycle analysis in Switzerland. Environmental Health 2022;21(1). Doi 10.1186/s12940-021-00814-y
4 Houziel C, Prothon, E, Trinh-Duc A. Carbon footprint of general practice: Retrospective case study of GP offices in a rural department of France. The Journal of Climate Change and Health 2023;14(100273). Doi 10.1016/j.joclim.2023.100273